Clinical diagnosis and treatment centers of rare diseasess
The clinical diagnosis and treatment center is a guarantee for patients with rare diseases to receive good quality medical services. As early as in 2011, in order to guarantee the diagnosis and treatment of children with Pompe disease, Gaucher's disease, Mucopolysaccharidosis, and Fabry disease, the Shanghai Children's Hospitalization Mutual Fund Management Office appointed three hospitals for this responsibility (2) . With increasing attention to prevention and treatment of rare diseases in recent years, the former Shanghai Municipal Health and Family Planning Commission (SMHFPC) officially established Shanghai Rare Diseases Diagnosis and Treatment Center, Shanghai Children's Rare Diseases Diagnosis and Treatment Center, and the first batch of 5 Shanghai Rare Diseases Specialist Clinics (Figure 1 ) in February 2018 (3, 4) . Identification of the above centers and outpatient clinics mainly follow the principles of early research, more case accumulation, rich clinical experience, greater social impact, and higher academic status. It also requires them to benchmark the highest and best standards internationally to build a domesticallyleading and internationally first-class rare disease diagnosis and treatment institution. Additionally, in order to speed up the construction of a first-class medical center city and implement the national strategy of the Yangtze River Delta integration, Shanghai has proposed to build a laboratory diagnostic center for rare
Summary
Shanghai has always attached importance to the prevention and treatment of rare diseases and has been at the forefront in China. 
Diagnosis and treatment procedure for rare diseases
Timely and reasonable diagnosis and treatment is one of the main demands of patients with rare diseases. At present, the rare disease diagnosis and treatment center or outpatient clinic in Shanghai has established a group of rare disease experts, which is participated in by many clinical specialties and medical technology departments and is organized by experts from the hospital, the provincial level and even the national level. The multiple disciplinary team (MDT) is adopted to diagnose and treat rare diseases (Figure 2 ). Meanwhile, organizations have also vigorously strengthened the construction of various laboratory diagnostic platforms, including molecular genetics, cytogenetics, and genome-wide platforms.
Newborn screening for early detection of rare diseases
At present, newborn screening plays a major role in screening of rare diseases. In 1981, screening of phenylketonuria among all newborns was first achieved nationwide in Shanghai (9) . In 2007, screening for congenital adrenal cortical hyperplasia and glucose-6-phosphate dehydrogenase deficiencywas available for all newborns. In addition, tandem mass spectrometry can be independently selected to detect a variety of rare diseases.
Referral information service for patients with rare diseases
Some rare disease diagnosis and treatment institutions have begun to implement patient registry, and established a patient's clinical information database and biobank. SFRD is also organizing construction of a registration 292
Figure1. The clinical diagnosis and treatment system of rare diseases in Shanghai.
It can be said that the Shanghai rare disease diagnosis and treatment service system has taken initial shape. This is not only a gospel for rare disease patients in Shanghai, but also for patients in the surrounding areas and even the whole country. This is of great significance for improving accessibility of diagnosis and treatment services for patients and reducing the burden on them.
As a highlight of domestic medical education and technology, Shanghai should continue to strengthen the research, teaching and training of rare diseases, and make the current medical staff training programs longterm and institutionalized, and further build regional and national rare disease diagnosis and treatment centers. Moreover, it is necessary to speed up establishment and improvement of the rare disease registration system and research collaboration network based on the clinical system, and comprehensively collect important data such as physiological, psychological and economic burdens of patients with rare diseases, and provide an important basis for the formulation of relevant research, diagnosis, treatment, policies and laws (12) . In addition, with the introduction of China's First National List of Rare Diseases (13, 14) and the prioritized evaluation and approval system for orphan drugs policy, Shanghai should actively seek relevant drugs to be used in the above-mentioned medical institutions as soon as possible, and further expand the scope of rare diseases to be diagnosed and treated.
platform for rare diseases patients in Shanghai. The first batch of registered units includes two centers and five specialist units (10) . In addition, Shanghai has also actively organized Rare Disease Day activities (three sessions so far) and academic annual conferences (nine sessions so far) to convey important information such as rare disease research, diagnosis, treatment, services, policies, etc., and to raise social concerns and awareness.
Knowledge training for increasing the awareness of rare diseases
Increasing the awareness of medical staff about rare diseases is of great significance in reducing the rate of misdiagnosis and missed diagnosis of rare diseases. In 
